Enanta Pharmaceuticals (ENTA) vs Opus Genetics (IRD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Opus Genetics (IRD) has outperformed Enanta Pharmaceuticals (ENTA) over the past year, gaining 117.2% versus a gain of 11.6%. Opus Genetics is the larger company by market cap ($366.9 million vs $360.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ENTA | IRD |
|---|---|---|
| Share price | $12.37 | $4.41 |
| Market cap | $360.28M | $366.89M |
| 1-day change | +1.64% | +0.68% |
| YTD return | -21.56% | +119.40% |
| 1-year return | +11.64% | +117.24% |
| 5-year return | — | +2.80% |
| EPS (TTM) | $-2.42 | $-1.27 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.15 | $7.07 |
| 52-week low | $10.20 | $1.70 |
| Distance from 52-week high | -27.87% | -37.62% |
| Average volume | 226.69K | 2.35M |
| Shares outstanding | 29.13M | 83.20M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRD has outperformed ENTA by 105.6 percentage points over the past year.
ENTA vs IRD FAQ
Which is bigger, Enanta Pharmaceuticals or Opus Genetics?
Opus Genetics (IRD) is larger, with a market capitalization of $366.89M compared with $360.28M for Enanta Pharmaceuticals (ENTA).
Which stock has performed better over the past year, ENTA or IRD?
IRD returned +117.24% over the past 12 months, compared with +11.64% for ENTA (price return, excluding dividends). Past performance does not predict future results.
Are Enanta Pharmaceuticals and Opus Genetics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.